Riverhead Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$28.1M Sell
349,707
-43,891
-11% -$3.52M 1.04% 5
2019
Q2
$31.5M Buy
393,598
+14,055
+4% +$1.08M 1.16% 3
2019
Q1
$30.1M Buy
379,543
+181,926
+92% +$13.6M 1.22% 3
2018
Q4
$14.4M Buy
197,617
+90,922
+85% +$6.42M 0.65% 19
2018
Q3
$7.22M Buy
106,695
+13,035
+14% +$830K 0.26% 97
2018
Q2
$5.42M Buy
93,660
+16,695
+22% +$942K 0.21% 124
2018
Q1
$4M Buy
76,965
+8,437
+12% +$456K 0.17% 167
2017
Q4
$3.68M Sell
68,528
-7,455
-10% -$413K 0.16% 179
2017
Q3
$4.64M Sell
75,983
-94,049
-55% -$5.7M 0.22% 123
2017
Q2
$10.4M Sell
170,032
-103,606
-38% -$6.31M 0.52% 31
2017
Q1
$16.6M Buy
273,638
+10,610
+4% +$644K 0.91% 10
2016
Q4
$14.8M Buy
263,028
+27,798
+12% +$1.63M 0.91% 9
2016
Q3
$14M Buy
235,230
+224,278
+2,048% +$13.1M 0.9% 9
2016
Q2
$630K Sell
10,952
-393,928
-97% -$21M 0.02% 555
2016
Q1
$20.1M Sell
404,880
-52,771
-12% -$2.58M 0.28% 92
2015
Q4
$23.1M Sell
457,651
-85,118
-16% -$4.29M 0.34% 69
2015
Q3
$25.6M Sell
542,769
-135,788
-20% -$7.21M 0.4% 65
2015
Q2
$36.9M Sell
678,557
-185,597
-21% -$10.4M 0.56% 39
2015
Q1
$47.4M Buy
864,154
+40,584
+5% +$2.3M 0.71% 22
2014
Q4
$44.6M Buy
823,570
+296,144
+56% +$16.5M 0.68% 27
2014
Q3
$29.8M Sell
527,426
-63,642
-11% -$3.57M 0.51% 46
2014
Q2
$32.6M Buy
591,068
+164,997
+39% +$9M 0.61% 36
2014
Q1
$23.1M Sell
426,071
-110,448
-21% -$5.72M 0.51% 47
2013
Q4
$25.6M Buy
536,519
+48,430
+10% +$2.21M 0.68% 28
2013
Q3
$22.2M Buy
488,089
+265,668
+119% +$12.1M 0.72% 33
2013
Q2
$9.86M Buy
+222,421
New +$9.93M 0.33% 82

Other funds holding MRK

Riverhead Capital Management's MRK Position: Q3 2019 in Review

Riverhead Capital Management reduced its Merck (MRK) stake by 11% in Q3 2019, selling an estimated $3.52M and leaving 349,707 shares worth $28.1M. The position accounts for 1.04% of the portfolio, ranked #5.

Riverhead Capital Management first reported a position in MRK in Q2 2013 and has held it in 26 quarters since. The position peaked at $47.4M in Q1 2015. 2,306 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Riverhead Capital Management held 349,707 shares of Merck worth $28.1M as of Q3 2019.
  • Riverhead Capital Management sold 43,891 Merck shares in Q3 2019, an estimated $3.52M.
  • Merck made up 1.04% of Riverhead Capital Management's portfolio in Q3 2019, its #5 holding.
  • Riverhead Capital Management first reported a position in Merck in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Merck position peaked at $47.4M in Q1 2015.
  • 2,306 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.